about
HIV Prevalence, Estimated Incidence, and Risk Behaviors Among People Who Inject Drugs in KenyaSelf-reported use of novel psychoactive substances among attendees of electronic dance music venues.Self-Reported Ecstasy/MDMA/"Molly" Use in a Sample of Nightclub and Dance Festival Attendees in New York City.Persistence of low drug treatment coverage for injection drug users in large US metropolitan areasThe multiple imputation method: a case study involving secondary data analysis.The potential impact and cost of focusing HIV prevention on young women and men: A modeling analysis in western Kenya.Complications of miliary tuberculosis: low mortality and predictive biomarkers from a UK cohort.Using the multiphase optimization strategy (MOST) to optimize an HIV care continuum intervention for vulnerable populations: a study protocol.It's a Process: Reactions to HIV Diagnosis and Engagement in HIV Care among High-Risk Heterosexuals.Eliminating Racial/Ethnic Disparities in AIDS Clinical Trials in the United States: A Qualitative Exploration of an Efficacious Social/Behavioral Intervention.L-dex ratio in detecting breast cancer-related lymphedema: reliability, sensitivity, and specificity.Gender-Specific Combination HIV Prevention for Youth in High-Burden Settings: The MP3 Youth Observational Pilot Study Protocol.Abuse-specific self-schemas and self-functioning: a prospective study of sexually abused youthPotential pathways from stigmatization and externalizing behavior to anger and dating aggression in sexually abused youth.Predictors of practice patterns for lymphedema care among oncology advanced practice nursesHIV-Infected Individuals Who Delay, Decline, or Discontinue Antiretroviral Therapy: Comparing Clinic- and Peer-Recruited CohortsAn effective intervention to reduce intravaginal practices among HIV-1 uninfected Kenyan women.Modified therapeutic community for co-occurring disorders: single investigator meta analysisChildhood sexual abuse, stigmatization, internalizing symptoms, and the development of sexual difficulties and dating aggression.Age differences in heroin and prescription opioid abuse among enrolees into opioid treatment programsThe Experience of Screening for HIV/AIDS Medical Studies among African-American/Black and Latino/Hispanic Persons Living with HIV/AIDS: A Mixed-Methods Exploration.ACT2 peer-driven intervention increases enrollment into HIV/AIDS medical studies among African Americans/Blacks and Hispanics: A cluster randomized controlled trial.A Brief Patient Self-administered Substance Use Screening Tool for Primary Care: Two-site Validation Study of the Substance Use Brief Screen (SUBS)Hybrid STTR intervention for heterosexuals using anonymous HIV testing and confidential linkage to care: a single arm exploratory trial using respondent-driven samplingA multi-method exploratory study of stress, coping, and substance use among high school youth in private schools.Powder cocaine and crack use in the United States: an examination of risk for arrest and socioeconomic disparities in useBehavioral intervention improves treatment outcomes among HIV-infected individuals who have delayed, declined, or discontinued antiretroviral therapy: a randomized controlled trial of a novel intervention.Correlates of Adherence to Varenicline Among HIV+ Smokers.Comorbidities and Quality of Life among Breast Cancer Survivors: A Prospective StudySymptom report in detecting breast cancer-related lymphedemaValidation of Self-Administered Single-Item Screening Questions (SISQs) for Unhealthy Alcohol and Drug Use in Primary Care Patients.Adverse psychosocial outcomes associated with drug use among US high school seniors: a comparison of alcohol and marijuana.Structure, process, and outcomes of care in a telemonitoring program for patients with type 2 diabetes.Detection of "bath salts" and other novel psychoactive substances in hair samples of ecstasy/MDMA/"Molly" users.Accuracy and Acceptability of Oral Fluid HIV Self-Testing in a General Adult Population in Kenya.The association between discrimination and the health of Sikh Asian Indians.Exploring How Substance Use Impedes Engagement along the HIV Care Continuum: A Qualitative StudySublingual buprenorphine/naloxone for chronic pain in at-risk patients: development and pilot test of a clinical protocol.Increasing and supporting the participation of persons of color living with HIV/AIDS in AIDS clinical trialsExploring Factors Associated with Recent HIV Testing among Heterosexuals at High Risk for HIV Infection Recruited with Venue-based Sampling
P50
Q28608358-B4FD3ECC-8965-4403-98B7-0A6D4B28A88FQ30389467-CA70D75B-7B19-49DE-B87D-6197710038F8Q30393293-F167EBEA-8BE5-49C9-849F-1C58EA3AC105Q30496986-8FF2635E-4584-4BED-960F-8CFCB7EF2A27Q30951932-98C2E368-88EA-4550-8708-2B66DCD0C526Q33558726-79F8426A-A0FD-4D6A-8876-E3911522D6CEQ33587149-613E263F-B4CD-4D68-9FFD-B8FD341B13BEQ33640486-9BFF6038-B9CB-4CA2-B7B5-E0CBA77A7098Q33653802-1CBCA726-BA20-46DC-B92C-1FC18FF1A9BDQ33686042-5983B9C0-D9F4-4235-94FD-9039A8FCFF9BQ33696199-D260160D-DCF5-41DF-9794-DDD95941942BQ33697680-16B5D174-0EBA-4926-9648-2EF0BE45998FQ33795379-65E5EB99-BC6D-44D8-8A00-C54C20A87386Q33869590-DC3F4F46-AC46-4D01-BA08-A33B026DC8B3Q33885689-42278E46-4CE7-43C8-B076-BB08FF18920CQ33907350-623733B7-1F3A-40DD-BC40-AA37FEA4AD3BQ34399672-B0A45016-B66C-47B7-B3E7-3BAEB420BF0AQ34681868-0A2F6D21-C83C-4CF9-A23B-28C3443671E2Q34930158-DE82FC67-0471-4D51-AEAF-1233C89FBFC7Q35052770-C2DE5781-20F3-44D7-967A-C57869D0DD06Q35646508-FCA61202-FD30-45BB-92A7-C2FC6AA78517Q35673171-10591240-4898-4C8A-8164-D871E2E72FD7Q35762993-82D0791C-25B9-49E5-8070-48C3CE038F2AQ35842728-6D877795-8DC4-4994-A34F-EADC8721FDECQ35880648-B7ED6804-BD00-470A-AB9C-874EB9ACFD45Q35945004-46351080-4B29-4AC1-9025-004B9AA7F32DQ36052895-2721B9A1-7D34-434F-9EFA-0BADC75FB5C8Q36087171-255AB0DC-8CC4-4D93-974A-4CE6849149E3Q36143720-51B5E60D-5ABE-4030-89B7-A418FD0DB5F0Q36208351-B216C1C1-A40C-4A90-81E2-86F75860C398Q36258417-A412FFB4-ED9D-47CE-83BD-4451D2116132Q36393003-CDFFD7F9-6AFB-4C7D-9C8F-B07FE1D2CD44Q36658176-5EA94A79-53F2-4915-9351-6C66DD0E6EC8Q36689382-95762EA5-C66C-406C-A03F-737FDE35808DQ36704467-7A227A5F-1981-4FCE-9FD3-5F81668B2126Q36736154-D258C6AC-CA06-49BB-8093-C0AE1FAD1520Q36777836-09F89D21-1403-4053-B252-0440DDC21832Q36779246-1EB9B216-F8E7-43C8-B84D-C558FFA51603Q36790642-8CEF6889-E221-4CAB-8725-1E3D239292FEQ36813072-A18A7B27-D0BB-413D-9EEB-7584F3771EE6
P50
description
researcher ORCID ID = 0000-0002-6931-9904
@en
wetenschapper
@nl
name
Charles M Cleland
@ast
Charles M Cleland
@en
Charles M Cleland
@es
Charles M Cleland
@nl
type
label
Charles M Cleland
@ast
Charles M Cleland
@en
Charles M Cleland
@es
Charles M Cleland
@nl
prefLabel
Charles M Cleland
@ast
Charles M Cleland
@en
Charles M Cleland
@es
Charles M Cleland
@nl
P106
P31
P496
0000-0002-6931-9904